PrecisionLife, CEO and Co-founder, Dr Steve Gardner, is presenting at the Sachs Associates 5th Annual Neuroscience Innovation Forum on Wednesday 23 March 2022.
The event will feature more than 12 hours of high-level keynotes, panel discussions, and spotlight showcases from pharma, biotech, digital therapeutics and neurotech companies.
SVP Alliance Management, Dr Sandy Hogg, will also be attending the Neuroscience Innovation Forum, participating in partnering meetings with biopharma companies throughout to discuss PrecisionLife’s unique ability to perform high-resolution patient stratification, generating a pipeline of new disease insights and targeted therapeutic candidates, including:-